vinorelbine
CHEBI:CHEBI_480999
Definition
A vinca alkaloid with a norvinblastine skeleton.
Chemical Information
- Molecular Formula
- C45H54N4O8
- Molecular Mass
- 778.93230
- Charge
- 0
- SMILES
- CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC
- InChI
- InChI=1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3/t28-,37-,38+,39+,42+,43+,44-,45-/m0/s1
- InChIKey
- GBABOYUKABKIAF-IELIFDKJSA-N
Alternative Names
- Nor-5'-anhydrovinblastine
- vinorelbina
- vinorelbine
- vinorelbinum
- methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-acetoxy-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate
Treatment Applications
-
labia minora carcinomaView Disease →
DOID:1293
-
labia majora carcinomaView Disease →
DOID:13389
-
cervical adenosarcomaView Disease →
DOID:4111
-
vagina leiomyosarcomaView Disease →
DOID:5283
-
vulvar leiomyosarcomaView Disease →
DOID:5286
-
pulmonary vein leiomyosarcomaView Disease →
DOID:7388
Drug Classification
-
methyl esterView Class →
CHEBI:25248
-
ring assemblyView Class →
CHEBI:36820
-
organic heterotetracyclic compoundView Class →
CHEBI:38163
-
organic heteropentacyclic compoundView Class →
CHEBI:38164
-
acetate esterView Class →
CHEBI:47622
-
vinca alkaloidView Class →
CHEBI:27288
-
t228390
-
t228409
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 39541
- oboInOwl#hasDbXref
- Patent:US4307100
- core#notation
- CHEBI:480999
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 39541
- oboInOwl#hasDbXref
- Patent:US4307100
- oboInOwl#id
- CHEBI:480999
- core#notation
- CHEBI:480999
- rxcui
- 1729422
- product_type
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- marketing_category
- BULK INGREDIENT
- dosage_form
- INJECTION, SOLUTION
- labeler_name
- Sagent Pharmaceuticals
- manufacturer_name
- Sagent Pharmaceuticals
- active_ingredient_strength
- 1 g/g
- route
- INTRAVENOUS
- marketing_start_date
- 20100602
- package_marketing_start_date
- 28-DEC-17
- generic_name
- Vinorelbine Tartrate
- brand_name
- Vinorelbine
- brand_name_base
- Vinorelbine
- product_ndc
- 25021-204
- application_number
- ANDA091106
- spl_id
- dfa03517-f452-450c-8eb6-d946c0350248
- active_ingredient_name
- VINORELBINE TARTRATE
- package_ndc
- 25021-204-05
- package_description
- 1 VIAL in 1 CARTON (25021-204-05) / 5 mL in 1 VIAL
- unii
- 253GQW851Q
- spl_set_id
- 10a70995-e04d-4044-b1dc-c9aa27460397
- upc
- 0345963607553
- pharm_class
- Vinca Alkaloids [CS]
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_47868
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_6202
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_112674
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect25700
- owl#annotatedSource
- t228290
- owl#someValuesFrom
- t2997533